Xi Liu
Founder bij BEIJING STRONG BIOTECHNOLOGIES,INC.
Vermogen: 179 M $ op 31-03-2024
Profiel
Xi Liu founded Beijing Strong Biotechnologies, Inc. in 2001, where he is working as General Manager & Director from 2011.
Dr. Liu also currently works at Fuzhou Maixin Biotech Co., Ltd., as Director from 2020.
Dr. Liu received his graduate degree in 1982 from Harbin Engineering University and doctorate degree in 1988 from Institute of Automation Chinese Academy of Sciences.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
30-06-2023 | 50 260 257 ( 19.76% ) | 134 M $ | 31-03-2024 | |
30-06-2023 | 16 753 419 ( 5.01% ) | 45 M $ | 31-03-2024 |
Actieve functies van Xi Liu
Bedrijven | Functie | Begin |
---|---|---|
BEIJING STRONG BIOTECHNOLOGIES,INC. | Founder | 29-03-2001 |
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Director/Board Member | 30-09-2020 |
Opleiding van Xi Liu
Harbin Engineering University | Graduate Degree |
Institute of Automation Chinese Academy of Sciences | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BEIJING STRONG BIOTECHNOLOGIES,INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |